Alexa N. King - Publications

Focusing on Diastolic Dysfunction to Achieve Consensus With the Term Diabetic Cardiomyopathy.

Journal: Diabetes

Published: March 16, 2026

The need to redefine diabetic cardiomyopathy as a unique clinical entity that requires pharmacotherapy.

Journal: Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques

Published: August 28, 2025

Alpha-linolenic acid regulates white adipose tissue lipolysis independent of background dietary protein.

Journal: The Journal of nutritional biochemistry

Published: August 08, 2025

Metformin alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy.

Journal: Journal of molecular and cellular cardiology plus

Published: June 18, 2025

Pathophysiological features of pre-clinical HFrEF and HFpEF models.

Journal: The Journal of physiology

Published: September 08, 2024

The key to our hearts: Unlocking fundamental sex differences in mouse cardiomyocyte calcium-cycling.

Journal: The Journal of physiology

Published: October 12, 2023

A reduction of skeletal muscle DHA content does not result in impaired whole body glucose tolerance or skeletal muscle basal insulin signaling in otherwise healthy mice.

Journal: American journal of physiology. Endocrinology and metabolism

Published: January 25, 2023

The ketogenic diet maintains insulin sensitivity and inhibits lipid accumulation in the liver.

Journal: The Journal of physiology

Published: September 26, 2022